SIRT6 and breast carcinoma: As several novel small molecule activators and inhibitors of SIRT6 are becoming available21,93–95, future pharmacological studies will be of pivotal importance to elucidate the role of SIRT6 and will help identify suitable breast cancer subtype-specific interventions.